Filtered By:
Condition: Mania

This page shows you your search results in order of relevance. This is page number 4.

Order by Relevance | Date

Total 407 results found since Jan 2013.

Post‐stroke mania: a rare but treatable presentation
Abstract Mania occurring for the first time in later life is uncommon; however, it can rarely occur as a consequence of stroke. Here, the authors present the case of an elderly man who developed secondary mania shortly following a haemorrhagic stroke, and who responded well to treatment with olanzapine. Copyright © 2014 John Wiley & Sons
Source: Progress in Neurology and Psychiatry - February 11, 2014 Category: Neurology Authors: Rajdeep Routh, Andrew Hill Tags: Case notes Source Type: research

GLUTAMATE RECEPTOR ANTIBODIES IN NEUROLOGICAL DISEASES: Anti-AMPA-GluR3 antibodies, Anti-NMDA-NR1 antibodies, Anti-NMDA-NR2A/B antibodies, Anti-mGluR1 antibodies or Anti-mGluR5 antibodies are present in subpopulations of patients with either: Epilepsy, Encephalitis, Cerebellar Ataxia, Systemic Lupus Erythematosus (SLE) and Neuropsychiatric SLE, Sjogren's syndrome, Schizophrenia, Mania or Stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate Blood Brain Barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and Ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Abstract Glutamate is the major excitatory neurotransmitter of the Central Nervous System (CNS), and it is crucially needed for numerous key neuronal functions. Yet, excess glutamate causes massive neuronal death and brain damage by excitotoxicity-detrimental over activation of glutamate receptors. Glutamate-mediated excitotoxicity is the main pathological process taking place in many types of acute and chronic CNS diseases and injuries. In recent years, it became clear that not only excess glutamate can cause massive brain damage, but that several types of anti-glutamate receptor antibodies, that are present in ...
Source: Herpes - August 1, 2014 Category: Infectious Diseases Authors: Levite M Tags: J Neural Transm Source Type: research

Subliminal galvanic-vestibular stimulation recalibrates the distorted visual and tactile subjective vertical in right-sided stroke
In conclusion, we found that GVS rapidly influences poststroke verticality deficits in the visual and tactile modality, thus highlighting the importance of the vestibular system in the multimodal elaboration of the subjective vertical.
Source: Neuropsychologia - March 5, 2015 Category: Neurology Source Type: research

Sensors, Vol. 16, Pages 735: An Approach to the Prototyping of an Optimized Limited Stroke Actuator to Drive a Low Pressure Exhaust Gas Recirculation Valve
The purpose of this article is to describe the design of a limited stroke actuator and the corresponding prototype to drive a Low Pressure (LP) Exhaust Gas Recirculation (EGR) valve for use in Internal Combustion Engines (ICEs). The direct drive actuator topology is an axial flux machine with two air gaps in order to minimize the rotor inertia and a bipolar surface-mounted permanent magnet in order to respect an 80° angular stroke. Firstly, the actuator will be described and optimized under constraints of a 150 ms time response, a 0.363 N·m minimal torque on an angular range from 0° to 80° and prototyping constraints. ...
Source: Sensors - May 19, 2016 Category: Biotechnology Authors: Christophe GutfrindLaurent DufourVincent LiebartJean-Claude VannierPierre Vidal Tags: Article Source Type: research

Mood Stabilizers and Stroke Risk: New Data Mood Stabilizers and Stroke Risk: New Data
Dr Peter Yellowlees talks about mood stabilizers and risk for stroke in bipolar disorder.Medscape Psychiatry
Source: Medscape Today Headlines - March 14, 2019 Category: Consumer Health News Tags: Psychiatry Commentary Source Type: news

Lithium intoxication in the pre-hospital care with stroke symptoms - Case report.
Authors: Peran D, Pukovcova K, Pekara J, Nesvadba M, Nedved V, Christian Cmorej P, Cmorej PC, Bohm P, Mamova A Abstract Lithium is widely used in psychiatry to treat bipolar affective disorders since 1970 but little is known about the incidence, clinical course and associated factors of acute lithium intoxication. Moderate and severe cases of lithium intoxication are rare. This case reports a patient with acute lithium intoxication (serum level of 3.7 mmol/L) with neurological symptoms imitating stroke, which affects the differential diagnosis in the pre-hospital and hospital care. Patient was treated with forced d...
Source: Neuroendocrinology Letters - June 13, 2019 Category: Endocrinology Tags: Neuro Endocrinol Lett Source Type: research

Review Neuropsychiatric outcomes of stroke
The most common neuropsychiatric outcomes of stroke are depression, anxiety, fatigue, and apathy, which each occur in at least 30% of patients and have substantial overlap of prevalence and symptoms. Emotional lability, personality changes, psychosis, and mania are less common but equally distressing symptoms that are also challenging to manage. The cause of these syndromes is not known, and there is no clear relation to location of brain lesion. There are important gaps in knowledge about how to manage these disorders, even for depression, which is the most studied syndrome.
Source: Lancet Neurology - April 15, 2014 Category: Neurology Authors: Maree L Hackett, Sebastian Köhler, John T O'Brien, Gillian E Mead Tags: Review Source Type: research

Retrospective Safety and Efficacy of the DeepTMS in a variety of pathologies including refractory Major Depression, Bipolar Depression, Parkinsońs Disease, negative symptoms of Schizophrenia and Stroke in a clinical setting; an update on the post-Marketing experience in Chile
Repetitive transcranial magnetic stimulation (rTMS) has been proposed as add-on for the treatment of various pathologies, including refractory Major Depression (MD), Bipolar Depression (BD), Parkinsońs Disease (PD), negative symptoms of Schizophrenia (NS) and Stroke (ST). However, the effectiveness of the conventional rTMS in clinical settings is currently being debated. The novel Deep TMS H-coils can effectively stimulate deeper and larger brain regions than conventional rTMS coils, including the complete thickness of motor and prefrontal cortices, suggesting greater potential clinical efficacy.
Source: BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation - September 1, 2014 Category: Neurology Authors: Jimmy Stehberg, Francisco Torres, Esteban Villalón, Raúl Riquelme Tags: Poster Source Type: research

Long-term Risk of Myocardial Infarction and Stroke in Bipolar I Disorder:A Population-Based Cohort Study
To estimate the risk of fatal and non-fatal myocardial infarction (MI) and stroke in patients with bipolar I disorder compared to people without bipolar I disorder.
Source: Journal of Affective Disorders - January 13, 2016 Category: Neurology Authors: Miguel L. Prieto, Louis A. Schenck, Jennifer L. Kruse, James P. Klaas, Alanna M. Chamberlain, William V. Bobo, Frank Bellivier, Marion Leboyer, Véronique L. Roger, Robert D. Brown, Walter A. Rocca, Mark A. Frye Tags: Research paper Source Type: research

Long-term risk of myocardial infarction and stroke in bipolar I disorder: A population-based Cohort Study
To estimate the risk of fatal and non-fatal myocardial infarction (MI) and stroke in patients with bipolar I disorder compared to people without bipolar I disorder.
Source: Journal of Affective Disorders - January 13, 2016 Category: Neurology Authors: Miguel L. Prieto, Louis A. Schenck, Jennifer L. Kruse, James P. Klaas, Alanna M. Chamberlain, William V. Bobo, Frank Bellivier, Marion Leboyer, Véronique L. Roger, Robert D. Brown, Walter A. Rocca, Mark A. Frye Tags: Research paper Source Type: research

Psychotropic Use and Risk of Stroke among Patients with Bipolar Disorders: 10-Year Nationwide Population Based Study
To investigate the association between psychotropic agents (including antipsychotics, antidepressants and mood stabilizers) and risk of stroke among patients with bipolar disorders.
Source: Journal of Affective Disorders - September 21, 2017 Category: Neurology Authors: Chi-Shin Wu, Kuan-Yi Wu, Yu-Ru Lo, Ya-Wen Huang, Yu-Ting Tsai, Yashiun Li, Hui-Ju Tsai Tags: Research paper Source Type: research

Response to the article entitled 'Mood stabilisers and risk of stroke in bipolar disorder'.
Authors: Kuppili PP, Singhai K, Nebhinani N PMID: 31012409 [PubMed - in process]
Source: The British Journal of Psychiatry for Mental Science - April 25, 2019 Category: Psychiatry Tags: Br J Psychiatry Source Type: research

Stroke Risk among Elderly Users of Haloperidol and Typical Antipsychotics vs. Atypical Antipsychotics: A Real-World Study from a US Health Insurance Claims Database
Antipsychotics are approved and prescribed to treat various conditions such as schizophrenia, mania, major depressive disorder, agitation, delusional disorder, psychosis, and Tourette's syndrome1. The haloperidol prescribing information2 in the United States (US) does not warn about the risk of stroke but has a black box warning for an increased risk of death among elderly patients with dementia-related psychosis treated with antipsychotic drugs. Nonetheless, antipsychotics are used for indications such as neuropsychiatric symptoms of dementia, in the presence or absence of psychosis; such use is not approved by the Food a...
Source: The American Journal of Geriatric Psychiatry - September 25, 2020 Category: Geriatrics Authors: Daniel Fife, Clair Blacketer, R. Karl Knight, James Weaver Source Type: research

Stroke Risk Among Elderly Users of Haloperidol and Typical Antipsychotics Versus Atypical Antipsychotics: A Real-World Study From a US Health Insurance Claims Database
Antipsychotics are approved and prescribed to treat various conditions such as schizophrenia, mania, major depressive disorder, agitation, delusional disorder, psychosis, and Tourette's syndrome.1 The haloperidol prescribing information2 in the United States (US) does not warn about the risk of stroke but has a black box warning for an increased risk of death among elderly patients with dementia-related psychosis treated with antipsychotic drugs. Nonetheless, antipsychotics are used for indications such as neuropsychiatric symptoms of dementia, in the presence or absence of psychosis; such use is not approved by the Food a...
Source: The American Journal of Geriatric Psychiatry - September 26, 2020 Category: Geriatrics Authors: Daniel Fife, Clair Blacketer, R. Karl Knight, James Weaver Tags: Regular Research Article Source Type: research

COVID-19 Has Numerous Neuropsychiatric Consequences, Report Finds
Anarticle appearing today in theJournal of Neuropsychiatry and Clinical Neurosciences provides a comprehensive overview of the neurological and psychiatric impact of the COVID-19 pandemic.“Although best known for its severe effects on respiratory function, SARS-CoV-2 produces a broad range of acute and chronic neurological and neuropsychiatric problems,” wrote Theodora Manolis, M.D., of Red Cross Hospital in Athens, Greece, and colleagues. “The COVID-19 pandemic has also had an important impact on the mental health of many individuals in the general population as a result of loss of loved ones, fear of calamity or de...
Source: Psychiatr News - July 20, 2021 Category: Psychiatry Tags: COVID-19 delirium depression headache hypoxia Journal of Neuropsychiatry and Clinical Neurosciences muscle pain neurological problems psychiatric problems psychosis stroke Source Type: research